Evolve Innovation Financials
| EDGE Etf | CAD 39.76 0.01 0.03% |
3 y Sharp Ratio (0.21) |
Evolve |
The data published in Evolve Innovation's official financial statements typically reflect Evolve Innovation's business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving Evolve Innovation's quantitative information. For example, before you start analyzing numbers published by Evolve accountants, it's essential to understand Evolve Innovation's liquidity, profitability, and earnings quality within the context of the Evolve Funds Group Inc. space in which it operates.
Evolve Innovation Etf Summary
Evolve Innovation competes with Brompton Global, Brompton North, Global Healthcare, and Brompton North. The Evolve ETF seeks to replicate, to the extent reasonably possible and before fees and expenses, the performance of the Solactive Global Innovation Index, or any successor thereto . EVOLVE INNOVATION is traded on Toronto Stock Exchange in Canada.| Instrument | Canada Etf |
| Exchange | Toronto Exchange |
| ISIN | CA30052W1032 |
| Region | Others |
| Investment Issuer | Others |
| Etf Family | Evolve Funds Group Inc. |
| Fund Category | Others |
| Portfolio Concentration | Others |
| Benchmark | Dow Jones Industrial |
| Phone | 844 370 4884 |
| Currency | CAD - Canadian Dollar |
You should never invest in Evolve Innovation without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Evolve Etf, because this is throwing your money away. Analyzing the key information contained in Evolve Innovation's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Evolve Innovation Key Financial Ratios
Evolve Innovation's financial ratios allow both analysts and investors to convert raw data from Evolve Innovation's financial statements into concise, actionable information that can be used to evaluate the performance of Evolve Innovation over time and compare it to other companies across industries.Evolve Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Evolve Innovation's current stock value. Our valuation model uses many indicators to compare Evolve Innovation value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Evolve Innovation competition to find correlations between indicators driving Evolve Innovation's intrinsic value. More Info.Evolve Innovation Index is one of the top ETFs in beta as compared to similar ETFs. It also is one of the top ETFs in one year return as compared to similar ETFs reporting about 18.17 of One Year Return per Beta. Comparative valuation analysis is a catch-all model that can be used if you cannot value Evolve Innovation by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Evolve Innovation's Etf. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Evolve Innovation Index Systematic Risk
Evolve Innovation's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Evolve Innovation volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Evolve Innovation Index correlated with the market. If Beta is less than 0 Evolve Innovation generally moves in the opposite direction as compared to the market. If Evolve Innovation Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Evolve Innovation Index is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Evolve Innovation is generally in the same direction as the market. If Beta > 1 Evolve Innovation moves generally in the same direction as, but more than the movement of the benchmark.
Evolve Innovation December 1, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Evolve Innovation help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Evolve Innovation Index. We use our internally-developed statistical techniques to arrive at the intrinsic value of Evolve Innovation Index based on widely used predictive technical indicators. In general, we focus on analyzing Evolve Etf price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Evolve Innovation's daily price indicators and compare them against related drivers.
| Downside Deviation | 0.9941 | |||
| Information Ratio | 0.0109 | |||
| Maximum Drawdown | 4.98 | |||
| Value At Risk | (0.97) | |||
| Potential Upside | 1.43 |
Other Information on Investing in Evolve Etf
Evolve Innovation financial ratios help investors to determine whether Evolve Etf is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Evolve with respect to the benefits of owning Evolve Innovation security.